Candriam SCA’s Zimmer Biomet ZBH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $1.25M | Hold |
14,531
| – | – | 0.01% | 569 |
|
|
2026
Q1 | $1.31M | Hold |
14,531
| – | – | 0.01% | 580 |
|
|
2025
Q4 | $1.31M | Buy |
14,531
+2,438
| +20% | +$231K | 0.01% | 555 |
|
|
2025
Q3 | $1.19M | Sell |
12,093
-1,209
| -9% | -$120K | 0.01% | 565 |
|
|
2025
Q2 | $1.21M | Sell |
13,302
-4,913
| -27% | -$475K | 0.01% | 578 |
|
|
2025
Q1 | $5.49M | Sell |
18,215
-3,554
| -16% | -$380K | 0.03% | 313 |
|
|
2024
Q4 | $2.3M | Buy |
21,769
+4,336
| +25% | +$465K | 0.01% | 485 |
|
|
2024
Q3 | $1.88M | Buy |
17,433
+724
| +4% | +$79K | 0.01% | 508 |
|
|
2024
Q2 | $1.81M | Sell |
16,709
-33,269
| -67% | -$3.92M | 0.01% | 504 |
|
|
2024
Q1 | $6.6M | Sell |
49,978
-4,878
| -9% | -$609K | 0.04% | 299 |
|
|
2023
Q4 | $6.68M | Buy |
54,856
+3,691
| +7% | +$412K | 0.05% | 304 |
|
|
2023
Q3 | $5.74M | Buy |
51,165
+8,534
| +20% | +$1.08M | 0.04% | 294 |
|
|
2023
Q2 | $6.21M | Sell |
42,631
-23,708
| -36% | -$3.22M | 0.04% | 305 |
|
|
2023
Q1 | $7.89M | Buy |
66,339
+3,748
| +6% | +$471K | 0.05% | 293 |
|
|
2022
Q4 | $7.98M | Sell |
62,591
-16,047
| -20% | -$1.86M | 0.05% | 311 |
|
|
2022
Q3 | $8.22M | Buy |
78,638
+16,268
| +26% | +$1.79M | 0.06% | 306 |
|
|
2022
Q2 | $6.55M | Sell |
62,370
-18,346
| -23% | -$2.18M | 0.05% | 288 |
|
|
2022
Q1 | $10.3M | Sell |
80,716
-2,649
| -3% | -$319K | 0.07% | 253 |
|
|
2021
Q4 | $10.3M | Buy |
83,365
+10,647
| +15% | +$1.39M | 0.07% | 263 |
|
|
2021
Q3 | $10.8M | Sell |
72,718
-92,464
| -56% | -$13.6M | 0.07% | 261 |
|
|
2021
Q2 | $26.6M | Buy |
165,182
+152,985
| +1,254% | +$24.8M | 0.18% | 133 |
|
|
2021
Q1 | $1.75M | Buy |
12,197
+9
| +0.1% | +$1.39K | 0.01% | 541 |
|
|
2020
Q4 | $1.82M | Buy |
12,188
+929
| +8% | +$131K | 0.01% | 553 |
|
|
2020
Q3 | $1.49M | Buy |
11,259
+1,213
| +12% | +$158K | 0.01% | 547 |
|
|
2020
Q2 | $1.16M | Sell |
10,046
-56,792
| -85% | -$6.54M | 0.01% | 578 |
|
|
2020
Q1 | $9.49M | Hold |
66,838
| – | – | 0.11% | 220 |
|
|
2019
Q4 | $9.71M | Sell |
66,838
-13,707
| -17% | -$1.89M | 0.1% | 222 |
|
|
2019
Q3 | $10.7M | Sell |
80,545
-86,663
| -52% | -$11.2M | 0.14% | 170 |
|
|
2019
Q2 | $19M | Buy |
167,208
+52,386
| +46% | +$6.14M | 0.24% | 96 |
|
|
2019
Q1 | $14.2M | Buy |
114,822
+15,483
| +16% | +$1.76M | 0.18% | 128 |
|
|
2018
Q4 | $10M | Buy |
99,339
+49,097
| +98% | +$5.52M | 0.15% | 157 |
|
|
2018
Q3 | $6.41M | Sell |
50,242
-70,245
| -58% | -$8.35M | 0.09% | 271 |
|
|
2018
Q2 | $13M | Buy |
120,487
+35,362
| +42% | +$3.85M | 0.21% | 123 |
|
|
2018
Q1 | $9.01M | Sell |
85,125
-19,333
| -19% | -$2.25M | 0.15% | 176 |
|
|
2017
Q4 | $12.2M | Buy |
104,458
+9,625
| +10% | +$1.09M | 0.21% | 130 |
|
|
2017
Q3 | $10.8M | Sell |
94,833
-6,462
| -6% | -$746K | 0.19% | 146 |
|
|
2017
Q2 | $12.6M | Buy |
101,295
+56,021
| +124% | +$6.64M | 0.24% | 112 |
|
|
2017
Q1 | $5.37M | Sell |
45,274
-77,371
| -63% | -$8.77M | 0.1% | 236 |
|
|
2016
Q4 | $12.3M | Buy |
122,645
+54,444
| +80% | +$5.84M | 0.28% | 98 |
|
|
2016
Q3 | $8.61M | Buy |
68,201
+55,806
| +450% | +$6.89M | 0.21% | 127 |
|
|
2016
Q2 | $1.45M | Buy |
12,395
+814
| +7% | +$92.1K | 0.04% | 366 |
|
|
2016
Q1 | $1.19M | Sell |
11,581
-5,554
| -32% | -$537K | 0.03% | 404 |
|
|
2015
Q4 | $1.71M | Sell |
17,135
-112,941
| -87% | -$11.1M | 0.05% | 322 |
|
|
2015
Q3 | $11.9M | Sell |
130,076
-65,451
| -33% | -$6.56M | 0.29% | 104 |
|
|
2015
Q2 | $20.7M | Buy |
195,527
+77,009
| +65% | +$8.52M | 0.43% | 59 |
|
|
2015
Q1 | $13.5M | Sell |
118,518
-38,854
| -25% | -$4.43M | 0.27% | 99 |
|
|
2014
Q4 | $17.3M | Buy |
+157,372
| New | +$16.6M | 0.36% | 81 |
|
Other funds holding ZBH
Candriam SCA's ZBH Position: Q2 2026 in Review
Candriam SCA held its Zimmer Biomet (ZBH) position steady in Q2 2026 at 14,531 shares worth $1.25M. The position accounts for 0.01% of the portfolio, ranked #569.
Candriam SCA first reported a position in ZBH in Q4 2014 and has held it in 47 quarters since. The position peaked at $26.6M in Q2 2021. 906 funds tracked by Wall St. Rank hold ZBH as of Q2 2026.
- Candriam SCA held 14,531 shares of Zimmer Biomet worth $1.25M as of Q2 2026.
- Candriam SCA left its Zimmer Biomet share count unchanged in Q2 2026.
- Zimmer Biomet made up 0.01% of Candriam SCA's portfolio in Q2 2026, its #569 holding.
- Candriam SCA first reported a position in Zimmer Biomet in Q4 2014 and has held it in 47 quarters since.
- Candriam SCA's Zimmer Biomet position peaked at $26.6M in Q2 2021.
- 906 funds tracked by Wall St. Rank held Zimmer Biomet as of Q2 2026.
Based on Candriam SCA's 13F filing for Q2 2026, filed 13 Aug 2026.